Eli Lilly licenses Peptron’s SmartDepot by October 7?

📡 Polymarket: 12%
Two different numbers on purpose: Polymarket's is the outside reference, Profet's is what actually moves credits here.

10.50Ᵽ best bid · 14.50Ᵽ best ask

Polymarket's price is shown for reference only -- this platform's own order book sets its own price, and the two can diverge.

Log in to trade this market.

Order book

How much do you disagree with this price?

Pick 1 (barely) to 5 (strongly) -- a pure sentiment vote, not a trade, not tied to credits.

Log in to add your own rating.

No one's rated this yet -- be the first.

Source

Polymarket (via UMA optimistic oracle) ✓ Verified source

Event cutoff

Oct. 7, 2026, midnight

Rules

This market will resolve to “Yes” if Eli Lilly signs a commercial licensing agreement, technology transfer agreement, or equivalent binding agreement with Peptron that grants Eli Lilly commercial rights to Peptron’s SmartDepot technology by the specified date, 11:59 PM Korea Standard Time. Otherwise, this market will resolve to “No”.

Only commercial licensing agreements, technology transfer agreements, or equivalent binding agreements that grant Eli Lilly direct commercial rights to develop, manufacture, sell, or otherwise commercialize Peptron’s SmartDepot technology will qualify.

Co-development agreements will not qualify. Extensions of the existing Technology Evaluation Agreement or other agreements which are non-binding or do not grant Eli Lilly direct commercial rights to SmartDepot will not qualify.

The primary resolution source for this market will be official information from Eli Lilly and Peptron; however, a consensus of credible reporting may also be used.